INK1117: A potent and orally efficacious PI3Kα-selective inhibitor for the treatment of cancer

被引：5

作者：

Jessen, Katayoun A. ^{[1
]}

Kessler, Linda ^{[1
]}

Kucharski, Jeff ^{[1
]}

Guo, Xin ^{[1
]}

Staunton, Jocelyn ^{[1
]}

Elia, Marikka ^{[1
]}

Janes, Matthew ^{[1
]}

Lan, Lucy ^{[1
]}

Wang, Shunyou ^{[1
]}

Stewart, Josh ^{[1
]}

Darjania, Levan ^{[1
]}

Li, Liansheng ^{[1
]}

Chan, Katrina ^{[1
]}

Martin, Michael ^{[1
]}

Ren, Pingda ^{[1
]}

Fruman, David ^{[2
]}

Rommel, Christian ^{[1
]}

Liu, Yi ^{[1
]}

机构：

[1] Intellikine, La Jolla, CA USA

[2] UC Irvine, Irvine, CA USA

来源：

CANCER RESEARCH | 2011年 / 71卷

关键词：

D O I：

10.1158/1538-7445.AM2011-4501

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4501

引用

页数：1

共 50 条

[1] Discovery of a Potent, Selective, and Orally Available PI3Kδ Inhibitor for the Treatment of Inflammatory Diseases
Erra, Montse
Taltavull, Joan
Greco, Angelique
Javier Bernal, Francisco
Francisco Caturla, Juan
Gracia, Jordi
Dominguez, Maria
Sabate, Mar
Paris, Stephane
Soria, Salome
Hernandez, Begona
Armengol, Clara
Cabedo, Judit
Bravo, Monica
Calama, Elena
Miralpeix, Montserrat
Lehner, Martin D.
[J]. ACS MEDICINAL CHEMISTRY LETTERS, 2017, 8 (01): : 118 - 123
[2] Targeting aberrant PI3K pathway signaling with XL147, a potent, selective and orally bioavailable PI3K inhibitor
Shapiro, Geoffrey I.
Edelman, Gerald
Calvo, Emiliano
Aggarwal, Sanjay K.
Laird, A. Douglas
[J]. MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3594S - 3594S
[3] Identification of PKI-179 as a potent and orally efficacious PI3 kinase inhibitor for the treatment of cancer
Chen, Zecheng
Venkatesan, Aranapakam M.
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
[4] In vitro characterization of AMG 511, a potent and selective class I PI3K inhibitor for the treatment of cancer
Caenepeel, Sean
Zhang, Nancy
Wang, Ling
Norman, Mark H.
Burgess, Terri
Radinsky, Robert
Kendall, Rick
Freeman, Daniel
Hughes, Paul E.
[J]. CANCER RESEARCH, 2012, 72
[5] Seletalisib: Characterization of a Novel, Potent, and Selective Inhibitor of PI3Kδ
Allen, Rodger A.
Brookings, Daniel C.
Powell, Mark J.
Delgado, Jean
Shuttleworth, Lindsay K.
Merriman, Mark
Fahy, Ian J.
Tewari, Roohi
Silva, John P.
Healy, Louise J.
Davies, Gareth C. G.
Twomey, Breda
Cutler, Rona M.
Kotian, Apoorva
Crosby, Andrea
McCluskey, Gillian
Watt, Gillian F.
Payne, Andrew
[J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2017, 361 (03): : 429 - 440
[6] Identification of ETP-46321, a potent and orally bioavailable PI3K α, δ inhibitor
Martinez Gonzalez, Sonia
Isabel Hernandez, Ana
Varela, Carmen
Rodriguez-Aristegui, Sonsoles
Lorenzo, Milagros
Rodriguez, Antonio
Rivero, Virginia
Ignacio Martin, Jose
Gustav Saluste, Carl
Ramos-Lima, Francisco
Cendon, Elena
Cebrian, David
Aguirre, Enara
Gomez-Casero, Elena
Albarran, Maribel
Alfonso, Patricia
Garcia-Serelde, Beatriz
Oyarzabal, Julen
Rabal, Obdulia
Mulero, Francisca
Gonzalez-Granda, Teresa
Link, Wolfgang
Fominaya, Jesus
Barbacid, Mariano
Bischoff, James R.
Pizcueta, Pilar
Pastor, Joaquin
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (10) : 3460 - 3466
[7] Identification of GNE-477, a potent and efficacious dual PI3K/mTOR inhibitor
Heffron, Timothy P.
Berry, Megan
Castanedo, Georgette
Chang, Christine
Chuckowree, Irina
Dotson, Jennafer
Folkes, Adrian
Gunzner, Janet
Lesnick, John D.
Lewis, Cristina
Mathieu, Simon
Nonomiya, Jim
Olivero, Alan
Pang, Jodie
Peterson, David
Salphati, Laurent
Sampath, Deepak
Sideris, Steve
Sutherlin, Daniel P.
Tsui, Vickie
Wan, Nan Chi
Wang, Shumei
Wong, Susan
Zhu, Bing-yan
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (08) : 2408 - 2411
[8] Discovery of a novel and potent mutant-selective inhibitor of PI3Kα
Gao, Mingming
Qi, Chao
Li, Zhentian
Fan, Qipeng
Wang, Liyang
Zhou, Fei
You, Lin
Zheng, Hewen
Li, Yu
Wu, Liangxing
Yao, Wenqing
Liu, Phillip C.
[J]. CANCER RESEARCH, 2024, 84 (06)
[9] Optimization and in vivo evaluation of pyrazolopyridines as a potent and selective PI3Kδ inhibitor
Hamajima, Toshihiro
Takahashi, Fumie
Kato, Koji
Sugano, Yukihito
Yamaki, Susumu
Moritomo, Ayako
Kubo, Satoshi
Nakamura, Koji
Yamagami, Kaoru
Hamakawa, Nozomu
Yokoo, Koji
Fukahori, Hidehiko
[J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (14) : 3917 - 3924
[10] Discovery of AZD8835, a potent and selective inhibitor of PI3Kα and PI3Kδ for the treatment of PIK3CA-dependent cancers
Barlaam, Bernard
Cosulich, Sabina
Delouvrie, Benedicte
Fitzek, Martina
Germain, Herve
Green, Stephen
Harris, Craig S.
Hudson, Kevin
Lambert-van der Brempt, Christine
Lamorlette, Maryannick
Antoine, Le Griffon
Morgentin, Remy
Ouvry, Gilles
Page, Ken
Pasquet, Georges
Ruston, Linette
Saleh, Twana
Vautier, Michel
Ward, Lara
[J]. CANCER RESEARCH, 2015, 75

← 1 2 3 4 5 →